Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
sox0407's Profile
Displaying 901-950 of 2184 result(s).
IPIX Innovation Pharmaceuticals Inc
11/01/2017 8:07:24 PM
Most of us came to this board becau (1)
IPIX Innovation Pharmaceuticals Inc
11/01/2017 7:31:15 PM
New investors, the most recent shor (3)
IPIX Innovation Pharmaceuticals Inc
10/31/2017 6:40:09 PM
Looks like noretreat wants more sha (1)
IPIX Innovation Pharmaceuticals Inc
10/31/2017 6:23:45 PM
New investors, the most recent shor (3)
IPIX Innovation Pharmaceuticals Inc
10/31/2017 3:36:41 PM
Some people asked me to delete Alan
IPIX Innovation Pharmaceuticals Inc
10/31/2017 3:26:07 PM
Glad to hear that P is on-track for
IPIX Innovation Pharmaceuticals Inc
10/31/2017 12:13:40 AM
OT - Judge denies request for injun
IPIX Innovation Pharmaceuticals Inc
10/30/2017 8:21:01 PM
I feel I provide good due diligence (3)
IPIX Innovation Pharmaceuticals Inc
10/30/2017 8:12:41 PM
Alan, I'll continue to respond even (5)
IPIX Innovation Pharmaceuticals Inc
10/30/2017 7:03:28 PM
Where's the proof? My unanswered qu (1)
IPIX Innovation Pharmaceuticals Inc
10/30/2017 6:47:38 PM
The most recent short interest is < (2)
IPIX Innovation Pharmaceuticals Inc
10/30/2017 6:44:40 PM
FINRA Short Interest of IPIX Settle (1)
IPIX Innovation Pharmaceuticals Inc
10/30/2017 5:09:30 PM
The stock went up to $4 due to outs (2)
IPIX Innovation Pharmaceuticals Inc
10/30/2017 4:59:49 PM
Another boogeyman argument. We live
IPIX Innovation Pharmaceuticals Inc
10/30/2017 4:45:01 PM
First you said the MMs are colluded (1)
IPIX Innovation Pharmaceuticals Inc
10/30/2017 4:35:01 PM
I would use a credible source. What
IPIX Innovation Pharmaceuticals Inc
10/30/2017 4:28:50 PM
I agree 100%. Alan was the one who (1)
IPIX Innovation Pharmaceuticals Inc
10/30/2017 4:23:35 PM
I don't need to include the link to (1)
IPIX Innovation Pharmaceuticals Inc
10/30/2017 4:16:27 PM
Aspire has sold at least 75% of the
IPIX Innovation Pharmaceuticals Inc
10/30/2017 4:14:09 PM
You have proved nothing with the bo (1)
IPIX Innovation Pharmaceuticals Inc
10/30/2017 3:38:47 PM
None of the naked shorts covered be (1)
IPIX Innovation Pharmaceuticals Inc
10/30/2017 3:53:11 AM
I said it before that Aspire is one (4)
IPIX Innovation Pharmaceuticals Inc
10/30/2017 3:24:04 AM
Actually 42 patients because the fi (2)
IPIX Innovation Pharmaceuticals Inc
10/29/2017 7:51:27 PM
If naked shorts can short as much s (2)
IPIX Innovation Pharmaceuticals Inc
10/29/2017 7:40:39 PM
Yes, naked shorting exists. I'm not (1)
IPIX Innovation Pharmaceuticals Inc
10/29/2017 6:29:21 PM
I expect legal short to decrease as (1)
IPIX Innovation Pharmaceuticals Inc
10/29/2017 6:20:58 PM
You seem to use the same link for t (1)
IPIX Innovation Pharmaceuticals Inc
10/29/2017 6:15:41 PM
You said you don't believe FINRA is (1)
IPIX Innovation Pharmaceuticals Inc
10/29/2017 12:06:40 AM
I wrote to IBD News Today several t (4)
IPIX Innovation Pharmaceuticals Inc
10/28/2017 10:13:53 PM
Too bad Alan doesn't think the same
IPIX Innovation Pharmaceuticals Inc
10/28/2017 9:52:28 PM
Alan said it before. I have a prett
IPIX Innovation Pharmaceuticals Inc
10/28/2017 9:47:07 PM
Agree 100%. Hopefully someone can c
IPIX Innovation Pharmaceuticals Inc
10/28/2017 8:07:33 PM
Article - New Weapons for the Germ
IPIX Innovation Pharmaceuticals Inc
10/28/2017 8:01:51 PM
Some of you might know that Pfizer (2)
IPIX Innovation Pharmaceuticals Inc
10/28/2017 7:04:29 PM
Some people believe naked shorting (2)
IPIX Innovation Pharmaceuticals Inc
10/28/2017 6:39:02 PM
My question is unanswered, as expec
IPIX Innovation Pharmaceuticals Inc
10/28/2017 6:13:36 PM
Since FINRA is a self-regulating or
IPIX Innovation Pharmaceuticals Inc
10/28/2017 6:05:51 PM
Just saw Eucrisa's commercial for e (2)
IPIX Innovation Pharmaceuticals Inc
10/27/2017 9:53:58 PM
Today's volume was 435,885 shares. (1)
IPIX Innovation Pharmaceuticals Inc
10/27/2017 9:47:00 PM
Since Alan uses FINRA as a source f
IPIX Innovation Pharmaceuticals Inc
10/27/2017 9:44:29 PM
The most recent short interest is < (1)
IPIX Innovation Pharmaceuticals Inc
10/27/2017 7:07:38 PM
I think she's satisfied with the an (1)
IPIX Innovation Pharmaceuticals Inc
10/27/2017 6:45:08 PM
Yeah I miss the good old days. Wish (1)
IPIX Innovation Pharmaceuticals Inc
10/27/2017 6:34:27 PM
Sure, if you don't mind dying from (2)
IPIX Innovation Pharmaceuticals Inc
10/27/2017 4:23:30 PM
Nice close on decent volume. Stock (3)
IPIX Innovation Pharmaceuticals Inc
10/27/2017 4:22:13 PM
Scott even deleted Bunny's post. Ta (1)
IPIX Innovation Pharmaceuticals Inc
10/26/2017 7:22:32 PM
The most recent short interest is < (2)
IPIX Innovation Pharmaceuticals Inc
10/26/2017 6:53:58 PM
Here are some detailed explanations (3)
IPIX Innovation Pharmaceuticals Inc
10/26/2017 6:45:40 PM
If you really want to know what the (2)
IPIX Innovation Pharmaceuticals Inc
10/26/2017 6:06:21 PM
As predicted, the stock will run up (1)
Go to page:
  • << First
  • < Previous
  • 18
  • 19
  • Next >

Recent Articles

  • Senhwa Biosciences Advances Cancer Treatment with NCI Support
  • Joby Aviation Eyes Defense Market Opportunities Amid Growth Plans
  • Implantica Unveils Significant 5-Year Study Results for RefluxStop
  • Harvia's 2025 Financial Progress and Future Outlook
  • A.P. Møller - Mærsk A/S Launches Next Phase of Buy-Back Plan
  • Uber's Optimism for Tesla's Robotaxi Innovation and Competition
  • CLIQ Group's Q2 2025 Financial Update and Future Outlook
  • Valeura Energy Inc. Reports Impressive Q2 Performance in 2025
  • Strong Performance Amid Market Volatility by A.P. Møller - Mærsk
  • Harvia's Strong Q2 2025 Review: Growth Amid Challenges
  • Accesso and Six Flags Renew Ticketing Partnership for 5 Years
  • Forecasting the Future: Aviation Connector Market Insights
  • Valeura Energy Reports Impressive Q2 Results and Future Outlook
  • AB Akola Group Investor Calendar Update for Upcoming Years
  • Amaroq's Upcoming Financial Results and Investor Engagement Strategy
  • Almirall and Absci Join Forces to Innovate in Dermatology with AI
  • Enhancing Shareholder Value: NBPE's Recent Buyback Activity
  • Foresight Group’s New Share Buyback Program Details
  • OSB Group Engages in Significant Share Buyback Initiative
  • A.P. Møller - Mærsk A/S Reports Strong Q2 2025 Results
  • Insights into TCM Group A/S Major Shareholder Changes
  • ForFarmers Reports Impressive Growth in H1 2025 Results
  • Expected Growth of Agricultural Adjuvants Market to USD 6.2B
  • Experience Art and Crypto Fusion at UNTOLD Romania with Bitget
  • CLIQ Group's Second Quarter Performance Amidst Challenges
  • Impact of Trump's Tariff Decision on US Consumers and Markets
  • Endeavour Mining Expands Share Buyback Program with Recent Action
  • ForFarmers Reports Strong Growth and Financial Resilience
  • HTX Takes Center Stage at Global Blockchain Conference
  • Revolutionizing Accounting: How QuickBooks Is Leading AI Change
  • Valneva Gets FDA Approval for Chikungunya Vaccine IXCHIQ® Updates
  • KBC Group Reports Impressive Second-Quarter Profit Growth
  • GAM Holding AG Reports Significant Growth and Partnership Updates
  • Lassila & Tikanoja Sees Steady Progress Amid Changing Markets
  • Elis Enhances Growth Trajectory with OCL Acquisition in Ireland
  • NORBIT Unveils Second Quarter Results Presentation Details
  • Nordecon's 2025 Half-Year Review: Growth and Challenges Ahead
  • Merko Ehitus Reports Strong Second Quarter Financial Results
  • LexinFintech Holdings Ltd. Announces Q2 Financial Results
  • Investors Urged to Act Before Deadline in Flywire's Case
  • Deadline Approaching: Neogen Corporation Shareholder Alert
  • SBM Offshore Achieves Strong Growth in Half-Year Earnings
  • Elis Expands Its Horizons with OCL Acquisition in Ireland
  • Lassila & Tikanoja's Strategic Demerger: A Path to Growth
  • KBC Group Achieves Impressive 2Q Financial Performance
  • Lassila & Tikanoja Initiates Procedure for Amendment of Notes
  • SBM Offshore Reports Strong Half Year 2025 Financial Results
  • LexinFintech Holdings Delivers Strong Q2 Financial Performance
  • Merko Ehitus Reports Strong Half-Year Results for 2025
  • Lassila & Tikanoja's Q2 Report: A Look at Progress and Challenges
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site